---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-25-070069"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2025-07-23T23:59:59+00:00"
generated_at: "2026-05-18T03:22:52.478052+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# DarioHealth shareholders authorize reverse stock split and increase in authorized shares

## Summary
- All seven director nominees elected with majority support; Hila Karah received the most 'against' votes (1.98M).
- Kesselman & Kesselman (PwC) ratified as independent auditor for FY2025; 40.1M for, 146k against.
- Amended 2020 Equity Compensation Plan approved; adds 6% annual share increase and authorizes RSU grants.
- Reverse stock split (2:1 to 25:1) authorized; implementation by Sept 15, 2025, at Board's discretion.
- Authorized common stock increased from 160M to 400M shares; approved by stockholders.

## SEC filing metadata
- accession: 0001104659-25-070069
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2025-07-23T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465925070069/0001104659-25-070069-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465925070069/tm2521560d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-25-070069
- JSON: https://secwatch.observer/filing/0001104659-25-070069.json
- Plain text: https://secwatch.observer/filing/0001104659-25-070069.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.